JGL’s prescription portfolio has been expanded with an analgesic from the “Anti-inflammatory and antirheumatic products” pharmacotherapeutic group, with the brand name:
Etorikoksib JGL 60 mg film-coated tablets
Etorikoksib JGL 90 mg film-coated tablets
14×60 mg, 14×90 mg
The product is indicated in adults and adolescents over the age of 16 for alleviating symptoms of chronic and acute pain in the following approved indications: osteoarthitis, rheumatoid arthritis and ankylosing spondylitis, pain and signs of inflammation related to acute uric arthritis (gout), and shortterm treatment of pain following a dental surgery procedure. Etorikoksib JGL is included in the CIHI supplemental list of drugs.